Table 1.
Patients`characteristics.
Table 2.
Clinical symptoms.
Table 3.
Characteristics of infections in EAS patients.
Fig 1.
a. Cortisol 0600 and 2400 in patients with (1) and without (2) infections. b. Cortisol 0600 and 2400 in NET (1) and non-NET (2) patients with infections. c. Cortisol 0600 and 2400 in GepNET (1) and non-GepNET (2) patients with infections.
Table 4.
Data of all EAS patients.
Table 5.
Correlation between ACTH, cortisol, chromogranin A and electrolytes in EAS patients.
Table 6.
Data of patients with and without NET.
Table 7.
Data of patients with and without GepNET.
Table 8.
Radiological data of EAS patients.
Fig 2.
Survival analysis based on type of tumor.
The difference in mortality in patients with and without neuroendocrine tumors of the gastrointestinal tract.
Fig 3.
Survival analysis based on type of tumor.
The difference in mortality in patients with and without metastases.
Table 9.
Tumors associated with EAS in our study and previously published series.